文献速递银屑病与炎症性皮肤病皮肤肿瘤

可见光对皮肤健康的影响:抗氧化剂和自由基淬灭剂在皮肤防护中的作用

Impact of visible light on skin health: The role of antioxidants and free radical quenchers in skin protection.
PubMed 文献 · J Am Acad Dermatol · 2021-12-20

可见光(VL)对皮肤健康的影响长期被低估;VL可在浅肤色人群(FST I-III)引起红斑,在深肤色人群(FST IV-VI)引起色素改变。自由基诱导是VL致皮肤病理的驱动机制之一,可诱导黑素生成和色素沉着。初步临床研究显示,含抗氧化剂组合的局部防晒产品可抑制FST I-III的VL+UV-A1诱导红斑,并减少FST IV-VI的色素沉着。

要点

  • VL可在FST I-III引起红斑,在FST IV-VI引起色素改变。
  • 自由基诱导是VL诱导皮肤病理的驱动机制之一,可诱导黑素生成和色素沉着。
  • 含抗氧化剂组合的局部防晒产品在初步临床研究中显示可抑制VL+UV-A1诱导的红斑和减少色素沉着。

核心结论

  • VL对皮肤健康有显著影响,抗氧化剂可能有助于防止色素性疾病的恶化,并可纳入光防护策略。
  • 皮肤科医生和公众必须认识到VL对皮肤的影响,尤其是对肤色较深患者,并了解现有的VL防护选择。

研究设计与样本

  • 原文为综述,检索范围未报告。

主要发现

  • VL可在FST I-III个体引起红斑,在FST IV-VI个体引起色素改变。
  • 自由基诱导导致活性物种生成,是VL诱导皮肤病理的驱动机制之一,可诱导黑素生成和色素沉着。
  • 初步临床研究显示,含抗氧化剂组合的局部防晒产品可抑制FST I-III的VL+UV-A1诱导红斑,并减少FST IV-VI的色素沉着。

关键数值与推荐

  • VL在FST I-III引起红斑,在FST IV-VI引起色素改变。
  • 含抗氧化剂组合的局部防晒产品在初步临床研究中显示可抑制VL+UV-A1诱导的红斑(FST I-III)和减少色素沉着(FST IV-VI)。

临床怎么用

  • 抗氧化剂可能有助于防止色素性疾病的恶化,并可纳入光防护策略。
  • 皮肤科医生和公众应认识到VL对皮肤的影响,尤其是对肤色较深患者,并了解现有的VL防护选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Until recently, the primary focus of photobiology has centered on the impact of UV radiation on skin health, including DNA damage and oncogenesis; however, the significant effects of visible light (VL) on skin remain grossly underreported. VL has been reported to cause erythema in individuals with light skin (Fitzpatrick skin types [FSTs] I-III) and pigmentary changes in individuals with dark skin types (FSTs IV-VI). These effects have importance in dermatologic diseases and potentially play a role in conditions aggravated by sun exposure, including phototoxicity in patients with FSTs I to III and post-inflammatory hyperpigmentation and melasma in patients with FSTs IV to VI. The induction of free radicals, leading to the generation of reactive species, is one driving mechanism of VL-induced skin pathologies, leading to the induction of melanogenesis and hyperpigmentation. Initial clinical studies have demonstrated the effectiveness of topical sunscreen with antioxidant combinations in inhibiting VL + UV-A1-induced erythema in FSTs I to III and reducing pigmentation in FSTs IV to VI. Antioxidants may help prevent the worsening of pigmentary disorders and can be incorporated into photoprotective strategies. It is essential that dermatologists and the public are aware of the impact of VL on skin, especially in patients with skin of color, and understand the available options for VL protection.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Lim HW, Kohli I, Ruvolo E, et al. Impact of visible light on skin health: The role of antioxidants and free radical quenchers in skin protection. J Am Acad Dermatol. 2021. PMID: 34942294. doi:10.1016/j.jaad.2021.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。